\-\ Texto\\:\\ \ \(0\)\
\-\ normal\\ vital\\ signs\\ \ \(0\)\
\-\ benign\\ abdominal\\ exam\ \(0\)\
\-\ no\\ laboratory\\ studies\ \(0\)\
\-\ the\\ patient\\ was\\ taken\\ to\\ the\\ operating\\ room\\ for\\ exploratory\\ laparotomy\\;\\ \\ segmental\\ ileal\\ resection\\ and\\ ileostomy\\ were\\ performed\\.\ \(0\)\
\-\ \\â\\€\\¢\\ anteroposterior\\ supine\\ portable\\ radiograph\\:\ \(0\)\
\-\ \\â\\€\\¢\\ abnormal\\ lucency\\ in\\ the\\ epigastric\\ region\\ due\\ to\\ anterior\\ free\\ air\ \(0\)\
\-\ \\â\\€\\¢\\ opaque\\ stripe\\ in\\ right\\ upper\\ quadrant\\ illustrating\\ the\\ falciform\\ ligament\\ \\(football\\ sign\\)\ \(0\)\
\-\ left\\ lateral\\ decubitus\\ portable\\ abdominal\\ radiograph\\:\ \(0\)\
\-\ lucency\\ between\\ the\\ right\\ liver\\ edge\\ and\\ lateral\\ right\\ diaphragm\ \(0\)\
\-\ opaque\\ stripe\\ in\\ area\\ of\\ falciform\\ liagment\ \(0\)\
\-\ ileal\\ perforation\\ secondary\\ to\\ indomethacin\\ administration\ \(0\)\
\-\ pneumoperitoneum\\ secondary\\ to\\:\ \(0\)\
\-\ pneumatosis\\ cystoides\\ intestinalis\\ \\(secondary\\ to\\ necrotizing\\ entercolitis\\)\ \(1\)\
\-\ complication\\ of\\ indomethacin\\ treatment\ \(0\)\
\-\ complication\\ of\\ positive\\ pressure\\ ventilation\ \(1\)\
\-\ extension\\ from\\ pneumomediastinum\ \(0\)\
\-\ hirschsprung\\â\\€\\™s\\ disease\ \(0\)\
\-\ older\\ children\\ \\â\\€\\“\\ blunt\\ abdominal\\ trauma\\;\\ perforated\\ ulcer\\,\\ meckel\\â\\€\\™s\\ diverticulum\\,\\ or\\ appendix\ \(0\)\
\-\ a\\ male\\ infant\\ was\\ born\\ at\\ an\\ estimated\\ gestational\\ age\\ of\\ 25\\ weeks\\.\\ \\ the\\ patient\\ was\\ intubated\\ and\\ placed\\ on\\ a\\ ventilator\\ due\\ to\\ respiratory\\ distress\\ in\\ the\\ delivery\\ room\\.\\ \\ on\\ day\\ of\\ life\\ 3\\,\\ the\\ patient\\ was\\ found\\ to\\ have\\ a\\ patent\\ ductus\\ arteriosus\\ \\(pda\\)\\.\\ \\ chest\\ radiographs\\ illustrated\\ increased\\ pulmonary\\ vascular\\ markings\\ consistent\\ with\\ the\\ clinical\\ suspicion\\ of\\ a\\ pda\\.\\ \\ the\\ patient\\ was\\ started\\ on\\ a\\ course\\ of\\ indomethacin\\ to\\ pharmacologically\\ close\\ the\\ pda\\.\\ \\ one\\ day\\ after\\ the\\ last\\ dose\\ of\\ indomethacin\\ \\(day\\ of\\ life\\ 6\\)\\,\\ the\\ patient\\ was\\ noted\\ to\\ have\\ bilious\\ residuals\\ from\\ his\\ orogastric\\ feeding\\ tube\\.\\ \\ an\\ abdominal\\ exam\\ was\\ benign\\.\\ \\ an\\ upper\\ gastrointestinal\\ study\\ was\\ performed\\ showing\\ normal\\ anatomy\\.\\ \\ chest\\ and\\ abdominal\\ radiographs\\ were\\ obtained\\ showing\\ no\\ signs\\ of\\ perforation\\.\\ \\ on\\ day\\ of\\ life\\ 7\\,\\ repeat\\ radiographs\\ were\\ performed\\ showing\\ free\\ air\\ in\\ the\\ peritoneal\\ cavity\\.\ \(0\)\
\-\ this\\ 25\\ week\\ old\\ premature\\ infant\\ developed\\ pneumoperitoneum\\ following\\ bowel\\ perforation\\ due\\ to\\ indomethacin\\ administration\\.\\ \\ the\\ radiographs\\ illustrate\\ the\\ presence\\ of\\ free\\ air\\ in\\ the\\ abdomen\\ through\\ hepatic\\ edge\\ sign\\,\\ football\\ \\(falciform\\ ligament\\)\\ sign\\,\\ anterior\\ lying\\ free\\ air\\ bubble\\.\\ \\ the\\ most\\ probable\\ differential\\ diagnoses\\ for\\ this\\ patient\\ includes\\ pneumatosis\\ cystoides\\ intestinalis\\ \\(secondary\\ to\\ necrotizing\\ entercolitis\\)\\ and\\ complication\\ of\\ positive\\ pressure\\ ventilation\\.\\ \\ this\\ patient\\â\\€\\™s\\ radiographs\\ show\\ no\\ signs\\ of\\ air\\ in\\ the\\ bowel\\ wall\\,\\ making\\ pneumatosis\\ intestinalis\\ less\\ likely\\,\\ and\\ no\\ evidence\\ of\\ pneumomediastinum\\.\\ \\ at\\ surgical\\ evaluation\\,\\ the\\ bowel\\ demonstrated\\ an\\ ileal\\ perforation\\.\\ \\ \\ \\ \ \(0\)\
\-\ numerous\\ reports\\ have\\ shown\\ an\\ association\\ between\\ indomethacin\\ and\\ intestinal\\ perforation\\.\\ \\ little\\ et\\ al\\ performed\\ a\\ study\\ comparing\\ surgical\\ ligation\\ versus\\ indomethacin\\ treatment\\ in\\ neonates\\ with\\ a\\ pda\\.\\ \\ seven\\ of\\ the\\ 167\\ indomethacin\\ patients\\ were\\ found\\ to\\ have\\ a\\ focal\\ intestinal\\ perforation\\.\\ \\ since\\ indomethacin\\ decreases\\ blood\\ flow\\ to\\ the\\ gastrointestinal\\ tract\\ \\(as\\ well\\ as\\ to\\ the\\ cerebral\\ hemispheres\\ and\\ kidneys\\)\\,\\ it\\ is\\ believed\\ that\\ perforations\\ are\\ secondary\\ to\\ decreased\\ mucosal\\ blood\\ flow\\.\\ \\ also\\,\\ as\\ a\\ prostaglandin\\ e2\\ inhibitor\\,\\ a\\ side\\ effect\\ is\\ altered\\ mucosal\\ wall\\ secretions\\ and\\ thus\\,\\ a\\ decrease\\ in\\ the\\ protective\\ barrier\\.\\ \\ although\\ indomethacin\\ therapy\\ has\\ been\\ the\\ first\\ line\\ choice\\ in\\ closing\\ pdas\\ in\\ neonates\\,\\ its\\ significant\\ complications\\ may\\ outweigh\\ the\\ benefits\\ of\\ avoiding\\ surgical\\ ligation\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ indomethacin\\:\\ 0\\.4964564146718372\ \(0\)\
\-\ perforation\\:\\ 0\\.20733703373042364\ \(0\)\
\-\ the\\:\\ 0\\.18991285305108566\ \(0\)\
\-\ pda\\:\\ 0\\.17380972981627754\ \(0\)\
\-\ falciform\\:\\ 0\\.15447534675968883\ \(0\)\
\-\ to\\:\\ 0\\.13727362205142246\ \(0\)\
\-\ intestinalis\\:\\ 0\\.13035729736220816\ \(0\)\
\-\ ileal\\:\\ 0\\.1277865662626925\ \(0\)\
\-\ of\\:\\ 0\\.12178369927104019\ \(0\)\
\-\ pneumatosis\\:\\ 0\\.120522940873938\ \(0\)\
\-\ air\\:\\ 0\\.11972001383184869\ \(0\)\
\-\ radiographs\\:\\ 0\\.11871273231675745\ \(0\)\
\-\ entercolitis\\:\\ 0\\.11708380326569832\ \(0\)\
\-\ free\\:\\ 0\\.11398113331330019\ \(0\)\
\-\ secondary\\:\\ 0\\.10848823575500872\ \(0\)\
\-\ cystoides\\:\\ 0\\.10298356450645922\ \(0\)\
\-\ was\\:\\ 0\\.1020620634849783\ \(0\)\
\-\ in\\:\\ 0\\.10017183848319179\ \(0\)\
\-\ abdominal\\:\\ 0\\.10010556693261781\ \(0\)\
\-\ complication\\:\\ 0\\.09974282271552407\ \(0\)\
\-\ opaque\\:\\ 0\\.09520405972663726\ \(0\)\
\-\ showing\\:\\ 0\\.09482165301434316\ \(0\)\
\-\ neonates\\:\\ 0\\.09408730434079376\ \(0\)\
\-\ day\\:\\ 0\\.09327107138115964\ \(0\)\
\-\ life\\:\\ 0\\.090096290991539\ \(0\)\
\-\ performed\\:\\ 0\\.08662630528583139\ \(0\)\
\-\ ligation\\:\\ 0\\.08466711059519198\ \(0\)\
\-\ stripe\\:\\ 0\\.08416372880575346\ \(0\)\
\-\ pneumoperitoneum\\:\\ 0\\.08416372880575346\ \(0\)\
\-\ patient\\:\\ 0\\.08334399504556758\ \(0\)\
\-\ pneumomediastinum\\:\\ 0\\.080348627249292\ \(0\)\
\-\ ventilation\\:\\ 0\\.07831788694719886\ \(0\)\
\-\ portable\\:\\ 0\\.07770660044575312\ \(0\)\
\-\ football\\:\\ 0\\.07684101922910866\ \(0\)\
\-\ signs\\:\\ 0\\.07675190074304081\ \(0\)\
\-\ necrotizing\\:\\ 0\\.07656499589353463\ \(0\)\
\-\ sign\\:\\ 0\\.07602952303243914\ \(0\)\
\-\ were\\:\\ 0\\.07547855104982874\ \(0\)\
\-\ intestinal\\:\\ 0\\.07408915634764222\ \(0\)\
\-\ edge\\:\\ 0\\.07386594045318512\ \(0\)\
\-\ have\\:\\ 0\\.07314799221983213\ \(0\)\
\-\ gastrointestinal\\:\\ 0\\.07220756080173268\ \(0\)\
\-\ bowel\\:\\ 0\\.07047747102018513\ \(0\)\
\-\ an\\:\\ 0\\.06999117964369303\ \(0\)\
\-\ mucosal\\:\\ 0\\.06896045416002478\ \(0\)\
\-\ and\\:\\ 0\\.06807872697746943\ \(0\)\
\-\ infant\\:\\ 0\\.06464197081412479\ \(0\)\
\-\ due\\:\\ 0\\.06312645607767546\ \(0\)\
\-\ lucency\\:\\ 0\\.06302287073556054\ \(0\)\
\-\ ligament\\:\\ 0\\.06292815008111433\ \(0\)\
\-\ room\\:\\ 0\\.059914080114422216\ \(0\)\
\-\ liagment\\:\\ 0\\.05854190163284916\ \(0\)\
\-\ pdas\\:\\ 0\\.05854190163284916\ \(0\)\
\-\ administration\\:\\ 0\\.058303273794093884\ \(0\)\
\-\ pharmacologically\\:\\ 0\\.05593991233606233\ \(0\)\
\-\ residuals\\:\\ 0\\.05593991233606233\ \(0\)\
\-\ prostaglandin\\:\\ 0\\.05593991233606233\ \(0\)\
\-\ pressure\\:\\ 0\\.05574571064845934\ \(0\)\
\-\ illustrating\\:\\ 0\\.05409377155001644\ \(0\)\
\-\ surgical\\:\\ 0\\.053375985934046036\ \(0\)\
\-\ orogastric\\:\\ 0\\.052661793506638944\ \(0\)\
\-\ perforations\\:\\ 0\\.052661793506638944\ \(0\)\
\-\ e2\\:\\ 0\\.052661793506638944\ \(0\)\
\-\ closing\\:\\ 0\\.052661793506638944\ \(0\)\
\-\ 25\\:\\ 0\\.051866059465122766\ \(0\)\
\-\ illustrate\\:\\ 0\\.05149178225322961\ \(0\)\
\-\ outweigh\\:\\ 0\\.05149178225322961\ \(0\)\
\-\ ileostomy\\:\\ 0\\.05050255183368895\ \(0\)\
\-\ illustrated\\:\\ 0\\.05050255183368895\ \(0\)\
\-\ benign\\:\\ 0\\.05029250887610212\ \(0\)\
\-\ protective\\:\\ 0\\.04964564146718372\ \(0\)\
\-\ avoiding\\:\\ 0\\.04964564146718372\ \(0\)\
\-\ study\\:\\ 0\\.048827911321875216\ \(0\)\
\-\ flow\\:\\ 0\\.0487651503634475\ \(0\)\
\-\ positive\\:\\ 0\\.04824372133819243\ \(0\)\
\-\ 167\\:\\ 0\\.048213663423806216\ \(0\)\
\-\ radiograph\\:\\ 0\\.04768496822969375\ \(0\)\
\-\ no\\:\\ 0\\.047616182014833794\ \(0\)\
\-\ between\\:\\ 0\\.04757037291104829\ \(0\)\
\-\ found\\:\\ 0\\.04737226063584664\ \(0\)\
\-\ comparing\\:\\ 0\\.04704365217039688\ \(0\)\
\-\ ductus\\:\\ 0\\.04605442175085622\ \(0\)\
\-\ hirschsprung\\:\\ 0\\.04561167412701938\ \(0\)\
\-\ arteriosus\\:\\ 0\\.045197511384351\ \(0\)\
\-\ ventilator\\:\\ 0\\.04480846528905534\ \(0\)\
\-\ inhibitor\\:\\ 0\\.04480846528905534\ \(0\)\
\-\ wall\\:\\ 0\\.04453641976389087\ \(0\)\
\-\ secretions\\:\\ 0\\.04444166287361005\ \(0\)\
\-\ on\\:\\ 0\\.04422327026960466\ \(0\)\
\-\ as\\:\\ 0\\.04411849534473666\ \(0\)\
\-\ barrier\\:\\ 0\\.044094697553440663\ \(0\)\
\-\ exploratory\\:\\ 0\\.043765533340973495\ \(0\)\
\-\ decubitus\\:\\ 0\\.043452432454069385\ \(0\)\
\-\ decreases\\:\\ 0\\.043452432454069385\ \(0\)\
\-\ anteroposterior\\:\\ 0\\.04259552208756416\ \(0\)\
\-\ blood\\:\\ 0\\.0425194165822609\ \(0\)\
\-\ benefits\\:\\ 0\\.04233355529759599\ \(0\)\
\-\ laparotomy\\:\\ 0\\.0416062916680235\ \(0\)\
\-\ anterior\\:\\ 0\\.0408779579489792\ \(0\)\
\-\ operating\\:\\ 0\\.04074938130151827\ \(0\)\
\-\ bubble\\:\\ 0\\.04055191048369907\ \(0\)\
\-\ perforated\\:\\ 0\\.03999353279077733\ \(0\)\
\-\ meckel\\:\\ 0\\.03999353279077733\ \(0\)\
\-\ seven\\:\\ 0\\.03947987510608989\ \(0\)\
\-\ bilious\\:\\ 0\\.039317403258140766\ \(0\)\
\-\ believed\\:\\ 0\\.03915894347359943\ \(0\)\
\-\ upper\\:\\ 0\\.039123986163540556\ \(0\)\
\-\ blunt\\:\\ 0\\.03885330022287656\ \(0\)\
\-\ intubated\\:\\ 0\\.03870576969765318\ \(0\)\
\-\ diagnoses\\:\\ 0\\.03870576969765318\ \(0\)\
\-\ chest\\:\\ 0\\.03864562307680688\ \(0\)\
\-\ estimated\\:\\ 0\\.038015071951696\ \(0\)\
\-\ probable\\:\\ 0\\.03788542521476326\ \(0\)\
\-\ this\\:\\ 0\\.037736047405645796\ \(0\)\
\-\ epigastric\\:\\ 0\\.03763373432004401\ \(0\)\
\-\ altered\\:\\ 0\\.03715816158519077\ \(0\)\
\-\ exam\\:\\ 0\\.036855548248925216\ \(0\)\
\-\ lying\\:\\ 0\\.036823270201248655\ \(0\)\
\-\ supine\\:\\ 0\\.03671541396135393\ \(0\)\
\-\ markings\\:\\ 0\\.03671541396135393\ \(0\)\
\-\ making\\:\\ 0\\.036609340551089165\ \(0\)\
\-\ right\\:\\ 0\\.03640979449595783\ \(0\)\
\-\ lateral\\:\\ 0\\.03633409023856419\ \(0\)\
\-\ ulcer\\:\\ 0\\.03630125121868555\ \(0\)\
\-\ premature\\:\\ 0\\.03610378040086634\ \(0\)\
\-\ little\\:\\ 0\\.03600727790246027\ \(0\)\
\-\ gestational\\:\\ 0\\.03554540270794461\ \(0\)\
\-\ hemispheres\\:\\ 0\\.03554540270794461\ \(0\)\
\-\ diaphragm\\:\\ 0\\.03545688688787089\ \(0\)\
\-\ born\\:\\ 0\\.034949994934133546\ \(0\)\
\-\ treatment\\:\\ 0\\.034875319438159365\ \(0\)\
\-\ suspicion\\:\\ 0\\.03478955419720366\ \(0\)\
\-\ segmental\\:\\ 0\\.034710813390766704\ \(0\)\
\-\ anatomy\\:\\ 0\\.034710813390766704\ \(0\)\
\-\ choice\\:\\ 0\\.034710813390766704\ \(0\)\
\-\ delivery\\:\\ 0\\.034405170140043836\ \(0\)\
\-\ peritoneal\\:\\ 0\\.034405170140043836\ \(0\)\
\-\ feeding\\:\\ 0\\.03433098092980573\ \(0\)\
\-\ dose\\:\\ 0\\.034185127032994686\ \(0\)\
\-\ older\\:\\ 0\\.03397237953172161\ \(0\)\
\-\ thus\\:\\ 0\\.03363276085827531\ \(0\)\
\-\ patent\\:\\ 0\\.03318560423721128\ \(0\)\
\-\ close\\:\\ 0\\.03312419424502643\ \(0\)\
\-\ appendix\\:\\ 0\\.033003109611047285\ \(0\)\
\-\ association\\:\\ 0\\.03294341341115777\ \(0\)\
\-\ vital\\:\\ 0\\.03259644809098839\ \(0\)\
\-\ diverticulum\\:\\ 0\\.03242975572647034\ \(0\)\
\-\ versus\\:\\ 0\\.032375140118415933\ \(0\)\
\-\ repeat\\:\\ 0\\.032108824093979874\ \(0\)\
\-\ kidneys\\:\\ 0\\.03151143536778027\ \(0\)\
\-\ decrease\\:\\ 0\\.03146407504055716\ \(0\)\
\-\ numerous\\:\\ 0\\.03092144531924813\ \(0\)\
\-\ started\\:\\ 0\\.030835305835143705\ \(0\)\
\-\ tract\\:\\ 0\\.030666419898492957\ \(0\)\
\-\ cavity\\:\\ 0\\.03022367227465612\ \(0\)\
\-\ children\\:\\ 0\\.029994458794201553\ \(0\)\
\-\ normal\\:\\ 0\\.029892447898362852\ \(0\)\
\-\ last\\:\\ 0\\.029773150821629096\ \(0\)\
\-\ distress\\:\\ 0\\.029489467275870627\ \(0\)\
\-\ taken\\:\\ 0\\.029251131839065986\ \(0\)\
\-\ tube\\:\\ 0\\.029251131839065986\ \(0\)\
\-\ hepatic\\:\\ 0\\.029151636897046942\ \(0\)\
\-\ respiratory\\:\\ 0\\.02911881178603055\ \(0\)\
\-\ al\\:\\ 0\\.029086153724648088\ \(0\)\
\-\ from\\:\\ 0\\.029077168668807947\ \(0\)\
\-\ et\\:\\ 0\\.028676064162193714\ \(0\)\
\-\ placed\\:\\ 0\\.028525062013833605\ \(0\)\
\-\ line\\:\\ 0\\.028525062013833605\ \(0\)\
\-\ includes\\:\\ 0\\.0284656421891982\ \(0\)\
\-\ reports\\:\\ 0\\.0284656421891982\ \(0\)\
\-\ shown\\:\\ 0\\.028377531488610226\ \(0\)\
\-\ complications\\:\\ 0\\.028036710060927117\ \(0\)\
\-\ at\\:\\ 0\\.027653542552688187\ \(0\)\
\-\ developed\\:\\ 0\\.027159087588614995\ \(0\)\
\-\ its\\:\\ 0\\.027087117168341685\ \(0\)\
\-\ course\\:\\ 0\\.02703958143089807\ \(0\)\
\-\ studies\\:\\ 0\\.026852883311952028\ \(0\)\
\-\ laboratory\\:\\ 0\\.026582641478655748\ \(0\)\
\-\ since\\:\\ 0\\.026516822489243717\ \(0\)\
\-\ presence\\:\\ 0\\.026302177222109775\ \(0\)\
\-\ extension\\:\\ 0\\.025913131126814117\ \(0\)\
\-\ obtained\\:\\ 0\\.02589329403153821\ \(0\)\
\-\ effect\\:\\ 0\\.025679039693417314\ \(0\)\
\-\ quadrant\\:\\ 0\\.025640841394849786\ \(0\)\
\-\ cerebral\\:\\ 0\\.025361379449155005\ \(0\)\
\-\ side\\:\\ 0\\.02528886686732924\ \(0\)\
\-\ liver\\:\\ 0\\.025252915539621862\ \(0\)\
\-\ although\\:\\ 0\\.024921063079452847\ \(0\)\
\-\ less\\:\\ 0\\.024904063611997547\ \(0\)\
\-\ first\\:\\ 0\\.02470350681421422\ \(0\)\
\-\ week\\:\\ 0\\.024621756725090593\ \(0\)\
\-\ vascular\\:\\ 0\\.02416710618116826\ \(0\)\
\-\ differential\\:\\ 0\\.023785186455524146\ \(0\)\
\-\ area\\:\\ 0\\.023714276394673557\ \(0\)\
\-\ resection\\:\\ 0\\.023465298370513293\ \(0\)\
\-\ show\\:\\ 0\\.023238703659820323\ \(0\)\
\-\ clinical\\:\\ 0\\.02319953388279873\ \(0\)\
\-\ age\\:\\ 0\\.0229819776175601\ \(0\)\
\-\ decreased\\:\\ 0\\.022674871402004332\ \(0\)\
\-\ demonstrated\\:\\ 0\\.022497423362399998\ \(0\)\
\-\ abdomen\\:\\ 0\\.02233611840148231\ \(0\)\
\-\ evaluation\\:\\ 0\\.02232475029361707\ \(0\)\
\-\ pulmonary\\:\\ 0\\.022313402288517158\ \(0\)\
\-\ his\\:\\ 0\\.02220101245944643\ \(0\)\
\-\ for\\:\\ 0\\.022190351054180043\ \(0\)\
\-\ abnormal\\:\\ 0\\.02199274719801944\ \(0\)\
\-\ following\\:\\ 0\\.021960472384581892\ \(0\)\
\-\ weeks\\:\\ 0\\.02193904566947826\ \(0\)\
\-\ region\\:\\ 0\\.0218964056773056\ \(0\)\
\-\ focal\\:\\ 0\\.0218964056773056\ \(0\)\
\-\ likely\\:\\ 0\\.021875191458939076\ \(0\)\
\-\ through\\:\\ 0\\.02179102900394089\ \(0\)\
\-\ been\\:\\ 0\\.021327412108990668\ \(0\)\
\-\ trauma\\:\\ 0\\.02125970829113045\ \(0\)\
\-\ significant\\:\\ 0\\.021135836831514213\ \(0\)\
\-\ therapy\\:\\ 0\\.021032858330984727\ \(0\)\
\-\ one\\:\\ 0\\.02095898936902933\ \(0\)\
\-\ evidence\\:\\ 0\\.02077795352134308\ \(0\)\
\-\ patients\\:\\ 0\\.02059320711020518\ \(0\)\
\-\ is\\:\\ 0\\.020049925022584212\ \(0\)\
\-\ consistent\\:\\ 0\\.019848931722910593\ \(0\)\
\-\ increased\\:\\ 0\\.019795101489378245\ \(0\)\
\-\ noted\\:\\ 0\\.01940875874111901\ \(0\)\
\-\ most\\:\\ 0\\.01905117629102084\ \(0\)\
\-\ it\\:\\ 0\\.01873840015780278\ \(0\)\
\-\ may\\:\\ 0\\.01842158877920136\ \(0\)\
\-\ after\\:\\ 0\\.017758455364555562\ \(0\)\
\-\ well\\:\\ 0\\.017725089803022252\ \(0\)\
\-\ also\\:\\ 0\\.01721868932972521\ \(0\)\
\-\ has\\:\\ 0\\.016720822241616605\ \(0\)\
\-\ male\\:\\ 0\\.01629866065338583\ \(0\)\
\-\ that\\:\\ 0\\.015885885884165427\ \(0\)\
\-\ disease\\:\\ 0\\.015366144696015148\ \(0\)\
\-\ with\\:\\ 0\\.014336054706157082\ \(0\)\
\-\ are\\:\\ 0\\.013890534847760504\ \(0\)\
\-\ or\\:\\ 0\\.012734779730484603\ \(0\)\
\-\ left\\:\\ 0\\.012487305160611306\ \(0\)\
\-\ old\\:\\ 0\\.010834077331704524\ \(0\)\
